Theme
Genomics '25: Gene Editing & Genetic Meds☆

CRSP-32.67%16.0%

NTLA-50.51%14.0%

BEAM-11.73%13.0%
SCTX+17.76%11.0%

PRME-42.54%9.0%

DTIL+9.35%8.0%

EDIT-30.39%8.0%

MGX-68.27%5.0%

SGMO0.00%5.0%

CRBU-82.50%4.0%

MGTX+19.86%4.0%

CLLS-70.02%3.0%
As of Oct 9, 2026, 4:27 AM ET
Genomics '25: Gene Editing & Genetic Meds Constituents
CRISPR Therapeutics AGCRSP | 16.0% | -3.65% | -6.75% | -5.63% | -9.02% | -3.81% | -16.13% | 47.53% | -32.67% | 11.59% | -48.86% | $4.86B |
Intellia Therapeutics, Inc.NTLA | 14.0% | 7.60% | 10.33% | 3.19% | 3.96% | 40.16% | -8.56% | 72.60% | -50.51% | -29.57% | -89.56% | $1.76B |
Beam Therapeutics Inc.BEAM | 13.0% | -0.69% | 1.53% | -2.28% | 0.86% | -11.26% | -13.56% | 33.12% | -11.73% | 5.76% | -70.56% | $2.53B |
Scribe Therapeutics Inc.SCTX | 11.0% | 9.45% | -11.67% | -34.61% | 11.97% | 17.76% | 17.76% | 17.76% | 17.76% | — | — | $311.2M |
Prime Medicine, Inc.PRME | 9.0% | -8.21% | 24.52% | 3.17% | 19.73% | 3.17% | -22.51% | 100.00% | -42.54% | -5.29% | -76.71% | $646.6M |
Editas Medicine, Inc.EDIT | 8.0% | 3.27% | 13.15% | 2.53% | 12.70% | 38.54% | 29.09% | 140.68% | -30.39% | -10.41% | -92.02% | $435.8M |
Precision BioSciences, Inc.DTIL | 8.0% | 2.88% | 3.04% | -11.31% | 1.58% | 54.57% | 53.10% | 37.10% | 9.35% | -29.73% | -97.90% | $177.5M |
Metagenomi, Inc. Common StockMGX | 5.0% | 0.86% | -12.88% | -13.63% | -10.12% | -38.69% | -34.66% | -25.32% | -68.27% | -50.59% | -93.38% | $37.4M |
Sangamo Therapeutics, Inc.SGMO | 5.0% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $1.80B |
Caribou Biosciences, Inc.CRBU | 4.0% | -22.06% | -60.88% | -66.58% | -60.56% | -69.74% | -74.67% | -44.11% | -82.50% | -74.54% | -97.49% | $47.7M |
MeiraGTx Holdings plcMGTX | 4.0% | -2.96% | -5.49% | -20.81% | -1.50% | 32.08% | 38.89% | 65.09% | 19.86% | 153.01% | -17.84% | $972.4M |
Cellectis S.A.CLLS | 3.0% | -6.72% | -15.54% | -60.06% | -10.71% | -74.17% | -67.78% | -0.79% | -70.02% | -36.22% | -86.28% | $125.5M |
| Theme return | — | 0.02% | -0.98% | -14.44% | 0.11% | 15.73% | 0.19% | 93.21% | -21.43% | 23.32% | -66.58% | — |
| Average | 8.3% | -1.69% | -5.05% | -17.17% | -3.43% | -0.95% | -8.25% | 36.97% | -28.47% | -6.00% | -70.05% | $1.14B |
| Median | 8.0% | -0.34% | -2.74% | -8.47% | 0.43% | 1.59% | -11.06% | 35.11% | -31.53% | -10.41% | -86.28% | $541.2M |
| Std Dev | 4.2% | 7.93% | 20.23% | 23.29% | 19.45% | 40.23% | 37.72% | 50.44% | 34.07% | 56.01% | 32.09% | $1.37B |
| Min | 3.0% | -22.06% | -60.88% | -66.58% | -60.56% | -74.17% | -74.67% | -44.11% | -82.50% | -74.54% | -97.90% | $37.4M |
| Max | 16.0% | 9.45% | 24.52% | 3.19% | 19.73% | 54.57% | 53.10% | 140.68% | 19.86% | 153.01% | 0.00% | $4.86B |
| % Positive Tickers | 41.67% | 41.67% | 25.00% | 50.00% | 50.00% | 33.33% | 66.67% | 25.00% | 27.27% | 0.00% |